Spots Global Cancer Trial Database for Prospective Registry of Ocular Melanoma Eye Plaque brachyTherapy Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Prospective Registry of Ocular Melanoma Eye Plaque brachyTherapy Patients
Official Title: Prospective Registry of Ocular Melanoma Eye Plaque brachyTherapy Patients (PROMPT)
Study ID: NCT06432660
Conditions
Interventions
Study Description
Brief Summary: This prospective registry study will evaluate doses utilized in eye plaque brachytherapy for the treatment of ocular melanoma and their associated outcomes. The goal of this study is to evaluate if lower doses of radiation can maintain high local control rates while minimizing the toxicities related to radiation therapy.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Dianda Ayala-Peacock, MD
Affiliation: Duke University Health System (DUHS)
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
